Article Text

Download PDFPDF
Care of the older person
Frailty is associated with a higher use of potentially inappropriate medications among community‐dwelling older adults
  1. Cathy Wernham1,
  2. Tomas Welsh1,2,3
  1. 1 Research Institute for the Care of Older People (RICE), Bath, UK
  2. 2 Older Person's Unit, Royal United Hospitals NHS Foundation Trust, Bath, UK
  3. 3 Institute of Clinical Neurosciences, University Of Bristol, Bristol, UK
  1. Correspondence to Dr Tomas Welsh, RICE, Research Institute for the Care of Older People, Bath BA1 3NG, UK; tomas.welsh{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: Bolina AF, Gomes NC, Marchiori GF, et al. Potentially inappropriate medication use and frailty phenotype among community‐dwelling older adults: a population‐based study. J Clin Nurs 2019;28:3914–22. doi: 10.1111/jocn.14976.

Implications for practice and research

  • Health professionals working in the community should engage in targeted medication review as part of routine practice.

  • Future research should prioritise testing methods of reducing potentially inappropriate medication (PIM) and their effectiveness in community populations.


Frailty and the use of potentially inappropriate medications are a growing concern across the globe. A number of national and international studies have found an association between frailty and PIM use. This study seeks to add to the pool of findings by investigating this association in a community-dwelling population already participating in a longitudinal study of health conditions. The authors set out to assess the association between frailty (as defined by the Fried phenotype)1 and PIM use (as defined by the Beer’s criteria).2 …

View Full Text


  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.